nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Topotecan—ovarian cancer	0.359	0.531	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.165	0.244	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.153	0.225	CiPCiCtD
Teniposide—TOP2A—Epirubicin—ovarian cancer	0.0355	0.186	CbGbCtD
Teniposide—ABCC6—Doxorubicin—ovarian cancer	0.0355	0.186	CbGbCtD
Teniposide—ABCG2—Topotecan—ovarian cancer	0.0263	0.137	CbGbCtD
Teniposide—TOP2A—Doxorubicin—ovarian cancer	0.0189	0.0989	CbGbCtD
Teniposide—ABCG2—Paclitaxel—ovarian cancer	0.013	0.0681	CbGbCtD
Teniposide—ABCG2—Carboplatin—ovarian cancer	0.0122	0.0641	CbGbCtD
Teniposide—ABCG2—Docetaxel—ovarian cancer	0.0094	0.0492	CbGbCtD
Teniposide—CYP3A5—Paclitaxel—ovarian cancer	0.0072	0.0377	CbGbCtD
Teniposide—ABCG2—Doxorubicin—ovarian cancer	0.00701	0.0367	CbGbCtD
Teniposide—CYP3A4—Topotecan—ovarian cancer	0.00567	0.0297	CbGbCtD
Teniposide—CYP3A5—Docetaxel—ovarian cancer	0.00521	0.0273	CbGbCtD
Teniposide—CYP2C9—Paclitaxel—ovarian cancer	0.00483	0.0253	CbGbCtD
Teniposide—CYP3A4—Vinorelbine—ovarian cancer	0.004	0.0209	CbGbCtD
Teniposide—CYP3A4—Paclitaxel—ovarian cancer	0.00281	0.0147	CbGbCtD
Teniposide—CYP3A4—Docetaxel—ovarian cancer	0.00203	0.0106	CbGbCtD
Teniposide—NCOA1—myometrium—ovarian cancer	0.00157	0.0623	CbGeAlD
Teniposide—CYP3A4—Doxorubicin—ovarian cancer	0.00151	0.00792	CbGbCtD
Teniposide—NCOA1—uterine cervix—ovarian cancer	0.00122	0.0485	CbGeAlD
Teniposide—NCOA1—decidua—ovarian cancer	0.00116	0.0462	CbGeAlD
Teniposide—NCOA1—endometrium—ovarian cancer	0.0011	0.0438	CbGeAlD
Teniposide—NCOA3—myometrium—ovarian cancer	0.00109	0.0434	CbGeAlD
Teniposide—NCOA1—uterus—ovarian cancer	0.00102	0.0404	CbGeAlD
Teniposide—NCOA3—Irinotecan—Topotecan—ovarian cancer	0.000927	0.474	CbGdCrCtD
Teniposide—NCOA1—bone marrow—ovarian cancer	0.000863	0.0343	CbGeAlD
Teniposide—NCOA3—uterine cervix—ovarian cancer	0.00085	0.0338	CbGeAlD
Teniposide—NCOA1—female gonad—ovarian cancer	0.000832	0.033	CbGeAlD
Teniposide—NCOA1—vagina—ovarian cancer	0.000827	0.0328	CbGeAlD
Teniposide—NCOA3—decidua—ovarian cancer	0.00081	0.0322	CbGeAlD
Teniposide—NCOA3—endometrium—ovarian cancer	0.000769	0.0305	CbGeAlD
Teniposide—NCOA1—testis—ovarian cancer	0.000738	0.0293	CbGeAlD
Teniposide—NCOA3—gonad—ovarian cancer	0.000713	0.0283	CbGeAlD
Teniposide—NCOA3—uterus—ovarian cancer	0.000708	0.0281	CbGeAlD
Teniposide—TOP2A—myometrium—ovarian cancer	0.000641	0.0255	CbGeAlD
Teniposide—NCOA3—female reproductive system—ovarian cancer	0.000637	0.0253	CbGeAlD
Teniposide—NCOA3—bone marrow—ovarian cancer	0.000601	0.0239	CbGeAlD
Teniposide—NCOA3—female gonad—ovarian cancer	0.000579	0.023	CbGeAlD
Teniposide—NCOA3—vagina—ovarian cancer	0.000576	0.0229	CbGeAlD
Teniposide—NCOA1—lymph node—ovarian cancer	0.000535	0.0212	CbGeAlD
Teniposide—NCOA3—testis—ovarian cancer	0.000514	0.0204	CbGeAlD
Teniposide—TOP2A—uterine cervix—ovarian cancer	0.000499	0.0198	CbGeAlD
Teniposide—TOP2A—decidua—ovarian cancer	0.000475	0.0189	CbGeAlD
Teniposide—TOP2A—endometrium—ovarian cancer	0.000451	0.0179	CbGeAlD
Teniposide—TOP2A—uterus—ovarian cancer	0.000416	0.0165	CbGeAlD
Teniposide—NCOA3—lymph node—ovarian cancer	0.000373	0.0148	CbGeAlD
Teniposide—TOP2A—bone marrow—ovarian cancer	0.000353	0.014	CbGeAlD
Teniposide—TOP2A—female gonad—ovarian cancer	0.00034	0.0135	CbGeAlD
Teniposide—TOP2A—vagina—ovarian cancer	0.000338	0.0134	CbGeAlD
Teniposide—ABCG2—myometrium—ovarian cancer	0.000319	0.0127	CbGeAlD
Teniposide—TOP2A—testis—ovarian cancer	0.000302	0.012	CbGeAlD
Teniposide—ABCG2—uterine cervix—ovarian cancer	0.000249	0.00988	CbGeAlD
Teniposide—ABCG2—decidua—ovarian cancer	0.000237	0.00941	CbGeAlD
Teniposide—CYP3A5—uterine cervix—ovarian cancer	0.000231	0.00917	CbGeAlD
Teniposide—ABCG2—endometrium—ovarian cancer	0.000225	0.00893	CbGeAlD
Teniposide—TOP2A—lymph node—ovarian cancer	0.000219	0.00868	CbGeAlD
Teniposide—ABCG2—uterus—ovarian cancer	0.000207	0.00823	CbGeAlD
Teniposide—CYP2C19—vagina—ovarian cancer	0.000198	0.00789	CbGeAlD
Teniposide—NCOA3—Idarubicin—Epirubicin—ovarian cancer	0.000181	0.0926	CbGdCrCtD
Teniposide—ABCG2—bone marrow—ovarian cancer	0.000176	0.00699	CbGeAlD
Teniposide—CYP2C9—female reproductive system—ovarian cancer	0.00017	0.00676	CbGeAlD
Teniposide—ABCG2—female gonad—ovarian cancer	0.000169	0.00673	CbGeAlD
Teniposide—ABCG2—vagina—ovarian cancer	0.000168	0.00669	CbGeAlD
Teniposide—NCOA3—Idarubicin—Doxorubicin—ovarian cancer	0.000168	0.0856	CbGdCrCtD
Teniposide—CYP3A5—female gonad—ovarian cancer	0.000157	0.00625	CbGeAlD
Teniposide—CYP3A5—vagina—ovarian cancer	0.000156	0.00621	CbGeAlD
Teniposide—ABCG2—testis—ovarian cancer	0.00015	0.00597	CbGeAlD
Teniposide—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.000149	0.076	CbGdCrCtD
Teniposide—CYP3A4—female reproductive system—ovarian cancer	0.00013	0.00515	CbGeAlD
Teniposide—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000127	0.0651	CbGdCrCtD
Teniposide—Leukopenia—Melphalan—ovarian cancer	0.000115	0.00169	CcSEcCtD
Teniposide—Anorexia—Chlorambucil—ovarian cancer	0.000115	0.00169	CcSEcCtD
Teniposide—Alopecia—Vinorelbine—ovarian cancer	0.000114	0.00168	CcSEcCtD
Teniposide—Extravasation—Epirubicin—ovarian cancer	0.000113	0.00167	CcSEcCtD
Teniposide—Chest pain—Topotecan—ovarian cancer	0.000112	0.00164	CcSEcCtD
Teniposide—Chest pain—Melphalan—ovarian cancer	0.00011	0.00161	CcSEcCtD
Teniposide—ABCG2—lymph node—ovarian cancer	0.000109	0.00433	CbGeAlD
Teniposide—Infection—Topotecan—ovarian cancer	0.000107	0.00157	CcSEcCtD
Teniposide—Oedema—Melphalan—ovarian cancer	0.000105	0.00154	CcSEcCtD
Teniposide—Thrombocytopenia—Topotecan—ovarian cancer	0.000105	0.00154	CcSEcCtD
Teniposide—Extravasation—Doxorubicin—ovarian cancer	0.000105	0.00154	CcSEcCtD
Teniposide—Decreased appetite—Chlorambucil—ovarian cancer	0.000105	0.00154	CcSEcCtD
Teniposide—Infection—Melphalan—ovarian cancer	0.000104	0.00153	CcSEcCtD
Teniposide—Anaemia—Vinorelbine—ovarian cancer	0.000104	0.00153	CcSEcCtD
Teniposide—Hyperhidrosis—Topotecan—ovarian cancer	0.000104	0.00152	CcSEcCtD
Teniposide—Pancytopenia—Paclitaxel—ovarian cancer	0.000103	0.00151	CcSEcCtD
Teniposide—Thrombocytopenia—Melphalan—ovarian cancer	0.000103	0.00151	CcSEcCtD
Teniposide—Tachycardia—Melphalan—ovarian cancer	0.000102	0.00151	CcSEcCtD
Teniposide—Anorexia—Topotecan—ovarian cancer	0.000102	0.0015	CcSEcCtD
Teniposide—Neutropenia—Paclitaxel—ovarian cancer	0.000101	0.00149	CcSEcCtD
Teniposide—Leukopenia—Vinorelbine—ovarian cancer	0.000101	0.00148	CcSEcCtD
Teniposide—Anorexia—Melphalan—ovarian cancer	0.0001	0.00147	CcSEcCtD
Teniposide—Feeling abnormal—Chlorambucil—ovarian cancer	9.93e-05	0.00146	CcSEcCtD
Teniposide—Gastrointestinal pain—Chlorambucil—ovarian cancer	9.85e-05	0.00145	CcSEcCtD
Teniposide—Liver function test abnormal—Docetaxel—ovarian cancer	9.83e-05	0.00144	CcSEcCtD
Teniposide—Hypotension—Melphalan—ovarian cancer	9.81e-05	0.00144	CcSEcCtD
Teniposide—Hypertension—Vinorelbine—ovarian cancer	9.71e-05	0.00143	CcSEcCtD
Teniposide—Urticaria—Chlorambucil—ovarian cancer	9.57e-05	0.00141	CcSEcCtD
Teniposide—Chest pain—Vinorelbine—ovarian cancer	9.57e-05	0.00141	CcSEcCtD
Teniposide—Dyspnoea—Topotecan—ovarian cancer	9.56e-05	0.00141	CcSEcCtD
Teniposide—Body temperature increased—Chlorambucil—ovarian cancer	9.52e-05	0.0014	CcSEcCtD
Teniposide—Abdominal pain—Chlorambucil—ovarian cancer	9.52e-05	0.0014	CcSEcCtD
Teniposide—Neuropathy peripheral—Paclitaxel—ovarian cancer	9.49e-05	0.00139	CcSEcCtD
Teniposide—TOP2A—Vindesine—Vinorelbine—ovarian cancer	9.46e-05	0.0484	CbGdCrCtD
Teniposide—Stomatitis—Paclitaxel—ovarian cancer	9.43e-05	0.00139	CcSEcCtD
Teniposide—Dyspnoea—Melphalan—ovarian cancer	9.36e-05	0.00138	CcSEcCtD
Teniposide—Decreased appetite—Topotecan—ovarian cancer	9.32e-05	0.00137	CcSEcCtD
Teniposide—Neuropathy—Epirubicin—ovarian cancer	9.28e-05	0.00136	CcSEcCtD
Teniposide—Decreased appetite—Melphalan—ovarian cancer	9.13e-05	0.00134	CcSEcCtD
Teniposide—Infection—Vinorelbine—ovarian cancer	9.12e-05	0.00134	CcSEcCtD
Teniposide—Bronchospasm—Docetaxel—ovarian cancer	9.05e-05	0.00133	CcSEcCtD
Teniposide—Thrombocytopenia—Vinorelbine—ovarian cancer	8.98e-05	0.00132	CcSEcCtD
Teniposide—Tachycardia—Vinorelbine—ovarian cancer	8.95e-05	0.00132	CcSEcCtD
Teniposide—Neoplasm—Epirubicin—ovarian cancer	8.94e-05	0.00131	CcSEcCtD
Teniposide—Hypersensitivity—Chlorambucil—ovarian cancer	8.88e-05	0.0013	CcSEcCtD
Teniposide—Feeling abnormal—Topotecan—ovarian cancer	8.84e-05	0.0013	CcSEcCtD
Teniposide—Gastrointestinal pain—Topotecan—ovarian cancer	8.77e-05	0.00129	CcSEcCtD
Teniposide—Anorexia—Vinorelbine—ovarian cancer	8.75e-05	0.00129	CcSEcCtD
Teniposide—Pancytopenia—Docetaxel—ovarian cancer	8.74e-05	0.00128	CcSEcCtD
Teniposide—Haemoglobin—Paclitaxel—ovarian cancer	8.73e-05	0.00128	CcSEcCtD
Teniposide—Haemorrhage—Paclitaxel—ovarian cancer	8.69e-05	0.00128	CcSEcCtD
Teniposide—Asthenia—Chlorambucil—ovarian cancer	8.64e-05	0.00127	CcSEcCtD
Teniposide—Neutropenia—Docetaxel—ovarian cancer	8.6e-05	0.00126	CcSEcCtD
Teniposide—Neuropathy—Doxorubicin—ovarian cancer	8.59e-05	0.00126	CcSEcCtD
Teniposide—Sepsis—Epirubicin—ovarian cancer	8.58e-05	0.00126	CcSEcCtD
Teniposide—Hypotension—Vinorelbine—ovarian cancer	8.57e-05	0.00126	CcSEcCtD
Teniposide—Pruritus—Chlorambucil—ovarian cancer	8.52e-05	0.00125	CcSEcCtD
Teniposide—Urticaria—Topotecan—ovarian cancer	8.52e-05	0.00125	CcSEcCtD
Teniposide—Body temperature increased—Topotecan—ovarian cancer	8.48e-05	0.00125	CcSEcCtD
Teniposide—Abdominal pain—Topotecan—ovarian cancer	8.48e-05	0.00125	CcSEcCtD
Teniposide—Urticaria—Melphalan—ovarian cancer	8.34e-05	0.00123	CcSEcCtD
Teniposide—Phlebitis—Epirubicin—ovarian cancer	8.33e-05	0.00122	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—ovarian cancer	8.27e-05	0.00122	CcSEcCtD
Teniposide—Diarrhoea—Chlorambucil—ovarian cancer	8.24e-05	0.00121	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—ovarian cancer	8.21e-05	0.00121	CcSEcCtD
Teniposide—Dyspnoea—Vinorelbine—ovarian cancer	8.18e-05	0.0012	CcSEcCtD
Teniposide—Flushing—Paclitaxel—ovarian cancer	8.06e-05	0.00118	CcSEcCtD
Teniposide—Neuropathy peripheral—Docetaxel—ovarian cancer	8.04e-05	0.00118	CcSEcCtD
Teniposide—Stomatitis—Docetaxel—ovarian cancer	7.99e-05	0.00117	CcSEcCtD
Teniposide—Decreased appetite—Vinorelbine—ovarian cancer	7.98e-05	0.00117	CcSEcCtD
Teniposide—Sepsis—Doxorubicin—ovarian cancer	7.94e-05	0.00117	CcSEcCtD
Teniposide—Hypersensitivity—Topotecan—ovarian cancer	7.9e-05	0.00116	CcSEcCtD
Teniposide—Chills—Paclitaxel—ovarian cancer	7.79e-05	0.00115	CcSEcCtD
Teniposide—Arrhythmia—Paclitaxel—ovarian cancer	7.76e-05	0.00114	CcSEcCtD
Teniposide—Hypersensitivity—Melphalan—ovarian cancer	7.74e-05	0.00114	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—ovarian cancer	7.71e-05	0.00113	CcSEcCtD
Teniposide—Asthenia—Topotecan—ovarian cancer	7.7e-05	0.00113	CcSEcCtD
Teniposide—Alopecia—Paclitaxel—ovarian cancer	7.68e-05	0.00113	CcSEcCtD
Teniposide—Vomiting—Chlorambucil—ovarian cancer	7.66e-05	0.00113	CcSEcCtD
Teniposide—Hepatic function abnormal—Doxorubicin—ovarian cancer	7.6e-05	0.00112	CcSEcCtD
Teniposide—Pruritus—Topotecan—ovarian cancer	7.59e-05	0.00112	CcSEcCtD
Teniposide—Feeling abnormal—Vinorelbine—ovarian cancer	7.56e-05	0.00111	CcSEcCtD
Teniposide—Asthenia—Melphalan—ovarian cancer	7.54e-05	0.00111	CcSEcCtD
Teniposide—Gastrointestinal pain—Vinorelbine—ovarian cancer	7.5e-05	0.0011	CcSEcCtD
Teniposide—Pruritus—Melphalan—ovarian cancer	7.43e-05	0.00109	CcSEcCtD
Teniposide—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	7.42e-05	0.038	CbGdCrCtD
Teniposide—Haemoglobin—Docetaxel—ovarian cancer	7.4e-05	0.00109	CcSEcCtD
Teniposide—Haemorrhage—Docetaxel—ovarian cancer	7.36e-05	0.00108	CcSEcCtD
Teniposide—Diarrhoea—Topotecan—ovarian cancer	7.34e-05	0.00108	CcSEcCtD
Teniposide—Urticaria—Vinorelbine—ovarian cancer	7.29e-05	0.00107	CcSEcCtD
Teniposide—Abdominal pain—Vinorelbine—ovarian cancer	7.25e-05	0.00107	CcSEcCtD
Teniposide—Body temperature increased—Vinorelbine—ovarian cancer	7.25e-05	0.00107	CcSEcCtD
Teniposide—Diarrhoea—Melphalan—ovarian cancer	7.19e-05	0.00106	CcSEcCtD
Teniposide—Nausea—Chlorambucil—ovarian cancer	7.16e-05	0.00105	CcSEcCtD
Teniposide—Anaemia—Paclitaxel—ovarian cancer	6.99e-05	0.00103	CcSEcCtD
Teniposide—Agitation—Paclitaxel—ovarian cancer	6.95e-05	0.00102	CcSEcCtD
Teniposide—Flushing—Docetaxel—ovarian cancer	6.83e-05	0.001	CcSEcCtD
Teniposide—Vomiting—Topotecan—ovarian cancer	6.82e-05	0.001	CcSEcCtD
Teniposide—Leukopenia—Paclitaxel—ovarian cancer	6.77e-05	0.000995	CcSEcCtD
Teniposide—Rash—Topotecan—ovarian cancer	6.76e-05	0.000994	CcSEcCtD
Teniposide—Hypersensitivity—Vinorelbine—ovarian cancer	6.76e-05	0.000993	CcSEcCtD
Teniposide—Dermatitis—Topotecan—ovarian cancer	6.76e-05	0.000993	CcSEcCtD
Teniposide—Headache—Topotecan—ovarian cancer	6.72e-05	0.000987	CcSEcCtD
Teniposide—Vomiting—Melphalan—ovarian cancer	6.68e-05	0.000981	CcSEcCtD
Teniposide—Liver function test abnormal—Epirubicin—ovarian cancer	6.63e-05	0.000974	CcSEcCtD
Teniposide—Rash—Melphalan—ovarian cancer	6.62e-05	0.000973	CcSEcCtD
Teniposide—Dermatitis—Melphalan—ovarian cancer	6.62e-05	0.000972	CcSEcCtD
Teniposide—Chills—Docetaxel—ovarian cancer	6.61e-05	0.000971	CcSEcCtD
Teniposide—Asthenia—Vinorelbine—ovarian cancer	6.58e-05	0.000967	CcSEcCtD
Teniposide—Arrhythmia—Docetaxel—ovarian cancer	6.58e-05	0.000967	CcSEcCtD
Teniposide—Hypertension—Paclitaxel—ovarian cancer	6.53e-05	0.000959	CcSEcCtD
Teniposide—Alopecia—Docetaxel—ovarian cancer	6.51e-05	0.000956	CcSEcCtD
Teniposide—Pruritus—Vinorelbine—ovarian cancer	6.49e-05	0.000954	CcSEcCtD
Teniposide—Chest pain—Paclitaxel—ovarian cancer	6.44e-05	0.000946	CcSEcCtD
Teniposide—Nausea—Topotecan—ovarian cancer	6.37e-05	0.000936	CcSEcCtD
Teniposide—Diarrhoea—Vinorelbine—ovarian cancer	6.28e-05	0.000923	CcSEcCtD
Teniposide—Nausea—Melphalan—ovarian cancer	6.24e-05	0.000917	CcSEcCtD
Teniposide—Confusional state—Paclitaxel—ovarian cancer	6.22e-05	0.000915	CcSEcCtD
Teniposide—Oedema—Paclitaxel—ovarian cancer	6.17e-05	0.000907	CcSEcCtD
Teniposide—Liver function test abnormal—Doxorubicin—ovarian cancer	6.13e-05	0.000901	CcSEcCtD
Teniposide—Infection—Paclitaxel—ovarian cancer	6.13e-05	0.000901	CcSEcCtD
Teniposide—Thrombocytopenia—Paclitaxel—ovarian cancer	6.04e-05	0.000888	CcSEcCtD
Teniposide—Tachycardia—Paclitaxel—ovarian cancer	6.02e-05	0.000885	CcSEcCtD
Teniposide—Hyperhidrosis—Paclitaxel—ovarian cancer	5.97e-05	0.000877	CcSEcCtD
Teniposide—Anaemia—Docetaxel—ovarian cancer	5.92e-05	0.000871	CcSEcCtD
Teniposide—Pancytopenia—Epirubicin—ovarian cancer	5.89e-05	0.000866	CcSEcCtD
Teniposide—Anorexia—Paclitaxel—ovarian cancer	5.88e-05	0.000865	CcSEcCtD
Teniposide—Vomiting—Vinorelbine—ovarian cancer	5.83e-05	0.000857	CcSEcCtD
Teniposide—Neutropenia—Epirubicin—ovarian cancer	5.8e-05	0.000853	CcSEcCtD
Teniposide—Rash—Vinorelbine—ovarian cancer	5.79e-05	0.00085	CcSEcCtD
Teniposide—Dermatitis—Vinorelbine—ovarian cancer	5.78e-05	0.000849	CcSEcCtD
Teniposide—Hypotension—Paclitaxel—ovarian cancer	5.77e-05	0.000848	CcSEcCtD
Teniposide—Headache—Vinorelbine—ovarian cancer	5.75e-05	0.000845	CcSEcCtD
Teniposide—Leukopenia—Docetaxel—ovarian cancer	5.74e-05	0.000843	CcSEcCtD
Teniposide—Hypertension—Docetaxel—ovarian cancer	5.53e-05	0.000813	CcSEcCtD
Teniposide—Dyspnoea—Paclitaxel—ovarian cancer	5.5e-05	0.000809	CcSEcCtD
Teniposide—Chest pain—Docetaxel—ovarian cancer	5.46e-05	0.000802	CcSEcCtD
Teniposide—Pancytopenia—Doxorubicin—ovarian cancer	5.45e-05	0.000801	CcSEcCtD
Teniposide—Nausea—Vinorelbine—ovarian cancer	5.45e-05	0.000801	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—ovarian cancer	5.42e-05	0.000797	CcSEcCtD
Teniposide—Stomatitis—Epirubicin—ovarian cancer	5.39e-05	0.000792	CcSEcCtD
Teniposide—Neutropenia—Doxorubicin—ovarian cancer	5.37e-05	0.000789	CcSEcCtD
Teniposide—Decreased appetite—Paclitaxel—ovarian cancer	5.36e-05	0.000788	CcSEcCtD
Teniposide—Sweating—Epirubicin—ovarian cancer	5.3e-05	0.000779	CcSEcCtD
Teniposide—Confusional state—Docetaxel—ovarian cancer	5.27e-05	0.000775	CcSEcCtD
Teniposide—Oedema—Docetaxel—ovarian cancer	5.23e-05	0.000769	CcSEcCtD
Teniposide—Infection—Docetaxel—ovarian cancer	5.2e-05	0.000764	CcSEcCtD
Teniposide—Thrombocytopenia—Docetaxel—ovarian cancer	5.12e-05	0.000753	CcSEcCtD
Teniposide—Tachycardia—Docetaxel—ovarian cancer	5.11e-05	0.00075	CcSEcCtD
Teniposide—TOP2A—Vincristine—Vinorelbine—ovarian cancer	5.1e-05	0.0261	CbGdCrCtD
Teniposide—Feeling abnormal—Paclitaxel—ovarian cancer	5.09e-05	0.000747	CcSEcCtD
Teniposide—Gastrointestinal pain—Paclitaxel—ovarian cancer	5.05e-05	0.000742	CcSEcCtD
Teniposide—Neuropathy peripheral—Doxorubicin—ovarian cancer	5.02e-05	0.000737	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—ovarian cancer	4.99e-05	0.000734	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—ovarian cancer	4.99e-05	0.000733	CcSEcCtD
Teniposide—Anorexia—Docetaxel—ovarian cancer	4.99e-05	0.000733	CcSEcCtD
Teniposide—Haemorrhage—Epirubicin—ovarian cancer	4.97e-05	0.00073	CcSEcCtD
Teniposide—Sweating—Doxorubicin—ovarian cancer	4.91e-05	0.000721	CcSEcCtD
Teniposide—Urticaria—Paclitaxel—ovarian cancer	4.9e-05	0.000721	CcSEcCtD
Teniposide—Hypotension—Docetaxel—ovarian cancer	4.89e-05	0.000718	CcSEcCtD
Teniposide—Body temperature increased—Paclitaxel—ovarian cancer	4.88e-05	0.000717	CcSEcCtD
Teniposide—Abdominal pain—Paclitaxel—ovarian cancer	4.88e-05	0.000717	CcSEcCtD
Teniposide—Dyspnoea—Docetaxel—ovarian cancer	4.66e-05	0.000685	CcSEcCtD
Teniposide—Haemoglobin—Doxorubicin—ovarian cancer	4.62e-05	0.000679	CcSEcCtD
Teniposide—Flushing—Epirubicin—ovarian cancer	4.61e-05	0.000677	CcSEcCtD
Teniposide—Haemorrhage—Doxorubicin—ovarian cancer	4.6e-05	0.000675	CcSEcCtD
Teniposide—Decreased appetite—Docetaxel—ovarian cancer	4.55e-05	0.000668	CcSEcCtD
Teniposide—Hypersensitivity—Paclitaxel—ovarian cancer	4.55e-05	0.000668	CcSEcCtD
Teniposide—Chills—Epirubicin—ovarian cancer	4.46e-05	0.000655	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—ovarian cancer	4.44e-05	0.000652	CcSEcCtD
Teniposide—Asthenia—Paclitaxel—ovarian cancer	4.43e-05	0.000651	CcSEcCtD
Teniposide—Alopecia—Epirubicin—ovarian cancer	4.39e-05	0.000645	CcSEcCtD
Teniposide—Pruritus—Paclitaxel—ovarian cancer	4.37e-05	0.000642	CcSEcCtD
Teniposide—Feeling abnormal—Docetaxel—ovarian cancer	4.31e-05	0.000633	CcSEcCtD
Teniposide—Gastrointestinal pain—Docetaxel—ovarian cancer	4.28e-05	0.000629	CcSEcCtD
Teniposide—Flushing—Doxorubicin—ovarian cancer	4.26e-05	0.000627	CcSEcCtD
Teniposide—Diarrhoea—Paclitaxel—ovarian cancer	4.22e-05	0.000621	CcSEcCtD
Teniposide—Abdominal pain—Docetaxel—ovarian cancer	4.14e-05	0.000608	CcSEcCtD
Teniposide—Body temperature increased—Docetaxel—ovarian cancer	4.14e-05	0.000608	CcSEcCtD
Teniposide—Chills—Doxorubicin—ovarian cancer	4.12e-05	0.000606	CcSEcCtD
Teniposide—Arrhythmia—Doxorubicin—ovarian cancer	4.1e-05	0.000603	CcSEcCtD
Teniposide—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	4.1e-05	0.021	CbGdCrCtD
Teniposide—Alopecia—Doxorubicin—ovarian cancer	4.06e-05	0.000597	CcSEcCtD
Teniposide—Anaemia—Epirubicin—ovarian cancer	4e-05	0.000587	CcSEcCtD
Teniposide—Agitation—Epirubicin—ovarian cancer	3.97e-05	0.000584	CcSEcCtD
Teniposide—Vomiting—Paclitaxel—ovarian cancer	3.92e-05	0.000577	CcSEcCtD
Teniposide—Etoposide—ABCB1—ovarian cancer	3.91e-05	1	CrCbGaD
Teniposide—Rash—Paclitaxel—ovarian cancer	3.89e-05	0.000572	CcSEcCtD
Teniposide—Dermatitis—Paclitaxel—ovarian cancer	3.89e-05	0.000571	CcSEcCtD
Teniposide—Leukopenia—Epirubicin—ovarian cancer	3.87e-05	0.000569	CcSEcCtD
Teniposide—Headache—Paclitaxel—ovarian cancer	3.87e-05	0.000568	CcSEcCtD
Teniposide—Hypersensitivity—Docetaxel—ovarian cancer	3.85e-05	0.000566	CcSEcCtD
Teniposide—Asthenia—Docetaxel—ovarian cancer	3.75e-05	0.000552	CcSEcCtD
Teniposide—Hypertension—Epirubicin—ovarian cancer	3.73e-05	0.000549	CcSEcCtD
Teniposide—Pruritus—Docetaxel—ovarian cancer	3.7e-05	0.000544	CcSEcCtD
Teniposide—Anaemia—Doxorubicin—ovarian cancer	3.7e-05	0.000543	CcSEcCtD
Teniposide—Chest pain—Epirubicin—ovarian cancer	3.68e-05	0.000541	CcSEcCtD
Teniposide—Agitation—Doxorubicin—ovarian cancer	3.68e-05	0.00054	CcSEcCtD
Teniposide—Nausea—Paclitaxel—ovarian cancer	3.67e-05	0.000539	CcSEcCtD
Teniposide—Leukopenia—Doxorubicin—ovarian cancer	3.58e-05	0.000526	CcSEcCtD
Teniposide—Diarrhoea—Docetaxel—ovarian cancer	3.58e-05	0.000526	CcSEcCtD
Teniposide—Confusional state—Epirubicin—ovarian cancer	3.56e-05	0.000523	CcSEcCtD
Teniposide—Oedema—Epirubicin—ovarian cancer	3.53e-05	0.000519	CcSEcCtD
Teniposide—Infection—Epirubicin—ovarian cancer	3.51e-05	0.000515	CcSEcCtD
Teniposide—Thrombocytopenia—Epirubicin—ovarian cancer	3.45e-05	0.000508	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—ovarian cancer	3.45e-05	0.000508	CcSEcCtD
Teniposide—Tachycardia—Epirubicin—ovarian cancer	3.44e-05	0.000506	CcSEcCtD
Teniposide—Hyperhidrosis—Epirubicin—ovarian cancer	3.41e-05	0.000501	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—ovarian cancer	3.41e-05	0.0005	CcSEcCtD
Teniposide—Anorexia—Epirubicin—ovarian cancer	3.36e-05	0.000494	CcSEcCtD
Teniposide—Vomiting—Docetaxel—ovarian cancer	3.33e-05	0.000489	CcSEcCtD
Teniposide—Rash—Docetaxel—ovarian cancer	3.3e-05	0.000485	CcSEcCtD
Teniposide—Hypotension—Epirubicin—ovarian cancer	3.3e-05	0.000485	CcSEcCtD
Teniposide—Dermatitis—Docetaxel—ovarian cancer	3.3e-05	0.000484	CcSEcCtD
Teniposide—Confusional state—Doxorubicin—ovarian cancer	3.29e-05	0.000484	CcSEcCtD
Teniposide—Headache—Docetaxel—ovarian cancer	3.28e-05	0.000482	CcSEcCtD
Teniposide—Oedema—Doxorubicin—ovarian cancer	3.26e-05	0.00048	CcSEcCtD
Teniposide—Infection—Doxorubicin—ovarian cancer	3.24e-05	0.000477	CcSEcCtD
Teniposide—Thrombocytopenia—Doxorubicin—ovarian cancer	3.2e-05	0.00047	CcSEcCtD
Teniposide—Tachycardia—Doxorubicin—ovarian cancer	3.19e-05	0.000468	CcSEcCtD
Teniposide—Hyperhidrosis—Doxorubicin—ovarian cancer	3.16e-05	0.000464	CcSEcCtD
Teniposide—Dyspnoea—Epirubicin—ovarian cancer	3.15e-05	0.000462	CcSEcCtD
Teniposide—Anorexia—Doxorubicin—ovarian cancer	3.11e-05	0.000457	CcSEcCtD
Teniposide—Nausea—Docetaxel—ovarian cancer	3.11e-05	0.000457	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—ovarian cancer	3.07e-05	0.000451	CcSEcCtD
Teniposide—Hypotension—Doxorubicin—ovarian cancer	3.05e-05	0.000448	CcSEcCtD
Teniposide—Dyspnoea—Doxorubicin—ovarian cancer	2.91e-05	0.000428	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—ovarian cancer	2.91e-05	0.000427	CcSEcCtD
Teniposide—Gastrointestinal pain—Epirubicin—ovarian cancer	2.89e-05	0.000424	CcSEcCtD
Teniposide—Decreased appetite—Doxorubicin—ovarian cancer	2.84e-05	0.000417	CcSEcCtD
Teniposide—Urticaria—Epirubicin—ovarian cancer	2.8e-05	0.000412	CcSEcCtD
Teniposide—Body temperature increased—Epirubicin—ovarian cancer	2.79e-05	0.00041	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—ovarian cancer	2.79e-05	0.00041	CcSEcCtD
Teniposide—Feeling abnormal—Doxorubicin—ovarian cancer	2.69e-05	0.000395	CcSEcCtD
Teniposide—Gastrointestinal pain—Doxorubicin—ovarian cancer	2.67e-05	0.000392	CcSEcCtD
Teniposide—Hypersensitivity—Epirubicin—ovarian cancer	2.6e-05	0.000382	CcSEcCtD
Teniposide—Urticaria—Doxorubicin—ovarian cancer	2.59e-05	0.000381	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—ovarian cancer	2.58e-05	0.000379	CcSEcCtD
Teniposide—Body temperature increased—Doxorubicin—ovarian cancer	2.58e-05	0.000379	CcSEcCtD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	2.58e-05	0.00069	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.55e-05	0.000682	CbGpPWpGaD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	2.55e-05	0.000681	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	2.53e-05	0.000678	CbGpPWpGaD
Teniposide—Asthenia—Epirubicin—ovarian cancer	2.53e-05	0.000372	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.5e-05	0.00067	CbGpPWpGaD
Teniposide—Pruritus—Epirubicin—ovarian cancer	2.5e-05	0.000367	CcSEcCtD
Teniposide—ABCG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.49e-05	0.000667	CbGpPWpGaD
Teniposide—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	2.49e-05	0.0127	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	2.49e-05	0.0127	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Epirubicin—ovarian cancer	2.49e-05	0.0127	CbGdCrCtD
Teniposide—NCOA1—Gene Expression—PARP1—ovarian cancer	2.48e-05	0.000665	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—ERBB2—ovarian cancer	2.47e-05	0.000662	CbGpPWpGaD
Teniposide—Diarrhoea—Epirubicin—ovarian cancer	2.41e-05	0.000355	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—ovarian cancer	2.41e-05	0.000353	CcSEcCtD
Teniposide—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	2.39e-05	0.000639	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—YAP1—ovarian cancer	2.38e-05	0.000637	CbGpPWpGaD
Teniposide—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	2.36e-05	0.000631	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.35e-05	0.00063	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—FASN—ovarian cancer	2.34e-05	0.000627	CbGpPWpGaD
Teniposide—Asthenia—Doxorubicin—ovarian cancer	2.34e-05	0.000344	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—MMP2—ovarian cancer	2.34e-05	0.000625	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.32e-05	0.000621	CbGpPWpGaD
Teniposide—Pruritus—Doxorubicin—ovarian cancer	2.31e-05	0.000339	CcSEcCtD
Teniposide—NCOA3—Metabolism—SLC5A5—ovarian cancer	2.31e-05	0.000617	CbGpPWpGaD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	2.3e-05	0.0118	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	2.3e-05	0.0118	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	2.3e-05	0.0118	CbGdCrCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	2.29e-05	0.000613	CbGpPWpGaD
Teniposide—Vomiting—Epirubicin—ovarian cancer	2.24e-05	0.00033	CcSEcCtD
Teniposide—Diarrhoea—Doxorubicin—ovarian cancer	2.23e-05	0.000328	CcSEcCtD
Teniposide—NCOA3—Metabolism—SLC2A1—ovarian cancer	2.23e-05	0.000596	CbGpPWpGaD
Teniposide—Rash—Epirubicin—ovarian cancer	2.22e-05	0.000327	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—ovarian cancer	2.22e-05	0.000327	CcSEcCtD
Teniposide—Headache—Epirubicin—ovarian cancer	2.21e-05	0.000325	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—CHEK2—ovarian cancer	2.19e-05	0.000585	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.18e-05	0.000584	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	2.17e-05	0.000581	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CTNNB1—ovarian cancer	2.17e-05	0.000579	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	2.16e-05	0.000578	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.15e-05	0.000575	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CYP1B1—ovarian cancer	2.14e-05	0.000571	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MMP9—ovarian cancer	2.12e-05	0.000568	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.11e-05	0.000564	CbGpPWpGaD
Teniposide—Nausea—Epirubicin—ovarian cancer	2.1e-05	0.000308	CcSEcCtD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.09e-05	0.00056	CbGpPWpGaD
Teniposide—Vomiting—Doxorubicin—ovarian cancer	2.08e-05	0.000305	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.07e-05	0.000554	CbGpPWpGaD
Teniposide—Rash—Doxorubicin—ovarian cancer	2.06e-05	0.000303	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—ovarian cancer	2.06e-05	0.000302	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.05e-05	0.000549	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND2—ovarian cancer	2.05e-05	0.000548	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—BRCA1—ovarian cancer	2.05e-05	0.000548	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—ERBB2—ovarian cancer	2.05e-05	0.000548	CbGpPWpGaD
Teniposide—Headache—Doxorubicin—ovarian cancer	2.05e-05	0.000301	CcSEcCtD
Teniposide—ABCG2—Metabolism—NME2—ovarian cancer	2.03e-05	0.000544	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.03e-05	0.000543	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PPP2R1A—ovarian cancer	2.01e-05	0.000539	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	2.01e-05	0.000537	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.98e-05	0.00053	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.97e-05	0.000527	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.97e-05	0.000527	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—FASN—ovarian cancer	1.94e-05	0.000519	CbGpPWpGaD
Teniposide—Nausea—Doxorubicin—ovarian cancer	1.94e-05	0.000285	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	1.93e-05	0.000517	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—SLC5A5—ovarian cancer	1.91e-05	0.00051	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—VEGFA—ovarian cancer	1.91e-05	0.00051	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	1.9e-05	0.000508	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPP2R1A—ovarian cancer	1.89e-05	0.000507	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—STAT3—ovarian cancer	1.89e-05	0.000505	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.88e-05	0.000504	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NRAS—ovarian cancer	1.88e-05	0.000504	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—BRCA2—ovarian cancer	1.85e-05	0.000496	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	1.85e-05	0.000494	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—SLC2A1—ovarian cancer	1.84e-05	0.000493	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	1.82e-05	0.000487	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.8e-05	0.000483	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MAPK3—ovarian cancer	1.8e-05	0.000483	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCNE1—ovarian cancer	1.79e-05	0.00048	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CTNNB1—ovarian cancer	1.79e-05	0.000479	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.79e-05	0.000478	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.77e-05	0.000474	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CYP1B1—ovarian cancer	1.77e-05	0.000473	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TYMS—ovarian cancer	1.76e-05	0.000472	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ABCB1—ovarian cancer	1.76e-05	0.000471	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MMP9—ovarian cancer	1.76e-05	0.00047	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—TYMS—ovarian cancer	1.73e-05	0.000462	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MAPK1—ovarian cancer	1.72e-05	0.000459	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EGFR—ovarian cancer	1.72e-05	0.000459	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.69e-05	0.000452	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	1.68e-05	0.000451	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	1.66e-05	0.000444	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.64e-05	0.00044	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.63e-05	0.000435	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—ovarian cancer	1.62e-05	0.000434	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.61e-05	0.00043	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.61e-05	0.00043	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—BIRC5—ovarian cancer	1.58e-05	0.000424	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—VEGFA—ovarian cancer	1.58e-05	0.000422	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPP2R1A—ovarian cancer	1.57e-05	0.000419	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—STAT3—ovarian cancer	1.56e-05	0.000418	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.56e-05	0.000417	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—ovarian cancer	1.56e-05	0.000417	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—ovarian cancer	1.54e-05	0.000412	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TERT—ovarian cancer	1.54e-05	0.000411	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.52e-05	0.000407	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MAPK3—ovarian cancer	1.49e-05	0.000399	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NME2—ovarian cancer	1.46e-05	0.00039	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ABCB1—ovarian cancer	1.45e-05	0.000389	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—TYMS—ovarian cancer	1.43e-05	0.000382	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—ESR1—ovarian cancer	1.43e-05	0.000382	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.42e-05	0.000381	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MAPK1—ovarian cancer	1.42e-05	0.00038	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—ovarian cancer	1.42e-05	0.00038	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.4e-05	0.000374	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CAV1—ovarian cancer	1.39e-05	0.000372	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—ovarian cancer	1.38e-05	0.000369	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.35e-05	0.000361	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—ovarian cancer	1.34e-05	0.000359	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.33e-05	0.000356	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—IL6—ovarian cancer	1.32e-05	0.000353	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.31e-05	0.000352	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYTB—ovarian cancer	1.31e-05	0.000351	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.3e-05	0.000348	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	1.3e-05	0.000347	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.27e-05	0.00034	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CG—ovarian cancer	1.27e-05	0.000339	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—ovarian cancer	1.22e-05	0.000325	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	1.19e-05	0.000318	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CAV1—ovarian cancer	1.15e-05	0.000308	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—BRIP1—ovarian cancer	1.14e-05	0.000306	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPP1CC—ovarian cancer	1.14e-05	0.000306	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.14e-05	0.000305	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—ovarian cancer	1.14e-05	0.000305	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NME2—ovarian cancer	1.13e-05	0.000301	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CD—ovarian cancer	1.11e-05	0.000298	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.11e-05	0.000297	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.1e-05	0.000294	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.1e-05	0.000293	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—IL6—ovarian cancer	1.09e-05	0.000292	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CG—ovarian cancer	1.05e-05	0.000281	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.04e-05	0.000278	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NME2—ovarian cancer	1.03e-05	0.000275	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—ovarian cancer	1.01e-05	0.000269	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1e-05	0.000268	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	9.92e-06	0.000266	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CB—ovarian cancer	9.71e-06	0.00026	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.55e-06	0.000256	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYTB—ovarian cancer	9.39e-06	0.000251	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	9.3e-06	0.000249	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CD—ovarian cancer	9.22e-06	0.000247	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—ovarian cancer	8.87e-06	0.000237	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.71e-06	0.000233	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTEN—ovarian cancer	8.39e-06	0.000225	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—BRIP1—ovarian cancer	8.2e-06	0.00022	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPP1CC—ovarian cancer	8.2e-06	0.00022	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	8.18e-06	0.000219	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CB—ovarian cancer	8.03e-06	0.000215	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	7.96e-06	0.000213	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	7.79e-06	0.000208	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.79e-06	0.000208	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—YAP1—ovarian cancer	7.68e-06	0.000206	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MAPK3—ovarian cancer	7.63e-06	0.000204	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—ovarian cancer	7.42e-06	0.000199	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MAPK3—ovarian cancer	7.32e-06	0.000196	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYTB—ovarian cancer	7.26e-06	0.000194	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—ovarian cancer	7.12e-06	0.00019	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.1e-06	0.00019	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.09e-06	0.00019	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MAPK1—ovarian cancer	6.96e-06	0.000186	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTEN—ovarian cancer	6.94e-06	0.000186	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NME2—ovarian cancer	6.77e-06	0.000181	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYTB—ovarian cancer	6.62e-06	0.000177	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.47e-06	0.000173	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPP1CC—ovarian cancer	6.34e-06	0.00017	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—BRIP1—ovarian cancer	6.34e-06	0.00017	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—FASN—ovarian cancer	6.26e-06	0.000168	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SLC5A5—ovarian cancer	6.16e-06	0.000165	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SLC2A1—ovarian cancer	5.95e-06	0.000159	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CA—ovarian cancer	5.92e-06	0.000158	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—ovarian cancer	5.85e-06	0.000156	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—BRIP1—ovarian cancer	5.78e-06	0.000155	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPP1CC—ovarian cancer	5.78e-06	0.000155	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP1B1—ovarian cancer	5.7e-06	0.000153	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—YAP1—ovarian cancer	5.5e-06	0.000147	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—ovarian cancer	5.15e-06	0.000138	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPP2R1A—ovarian cancer	5.06e-06	0.000135	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CA—ovarian cancer	4.9e-06	0.000131	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—ovarian cancer	4.84e-06	0.000129	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ABCB1—ovarian cancer	4.7e-06	0.000126	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.62e-06	0.000124	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TYMS—ovarian cancer	4.61e-06	0.000123	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—FASN—ovarian cancer	4.49e-06	0.00012	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SLC5A5—ovarian cancer	4.41e-06	0.000118	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYTB—ovarian cancer	4.36e-06	0.000117	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SLC2A1—ovarian cancer	4.26e-06	0.000114	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—YAP1—ovarian cancer	4.25e-06	0.000114	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.21e-06	0.000113	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.21e-06	0.000113	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP1B1—ovarian cancer	4.09e-06	0.000109	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—ovarian cancer	4e-06	0.000107	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—YAP1—ovarian cancer	3.88e-06	0.000104	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.84e-06	0.000103	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.81e-06	0.000102	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.81e-06	0.000102	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CAV1—ovarian cancer	3.72e-06	9.94e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.7e-06	9.9e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	3.62e-06	9.7e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—FASN—ovarian cancer	3.47e-06	9.28e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.41e-06	9.13e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CG—ovarian cancer	3.38e-06	9.06e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.37e-06	9.03e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ABCB1—ovarian cancer	3.36e-06	9e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TYMS—ovarian cancer	3.3e-06	8.84e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.29e-06	8.82e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.23e-06	8.63e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—FASN—ovarian cancer	3.16e-06	8.46e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.16e-06	8.45e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.11e-06	8.32e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3e-06	8.04e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CD—ovarian cancer	2.98e-06	7.96e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.94e-06	7.87e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.88e-06	7.71e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.8e-06	7.5e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.79e-06	7.46e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CAV1—ovarian cancer	2.66e-06	7.12e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.6e-06	6.96e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CB—ovarian cancer	2.59e-06	6.94e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—YAP1—ovarian cancer	2.56e-06	6.85e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TYMS—ovarian cancer	2.55e-06	6.84e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.55e-06	6.84e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.54e-06	6.8e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CG—ovarian cancer	2.43e-06	6.49e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.37e-06	6.35e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TYMS—ovarian cancer	2.33e-06	6.23e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTEN—ovarian cancer	2.24e-06	6e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CD—ovarian cancer	2.13e-06	5.71e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—FASN—ovarian cancer	2.09e-06	5.58e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CAV1—ovarian cancer	2.06e-06	5.51e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.05e-06	5.49e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.98e-06	5.3e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.97e-06	5.26e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.9e-06	5.08e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CAV1—ovarian cancer	1.88e-06	5.02e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.87e-06	5.02e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.86e-06	4.97e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.79e-06	4.8e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.71e-06	4.57e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.68e-06	4.51e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.65e-06	4.41e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTEN—ovarian cancer	1.61e-06	4.3e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CA—ovarian cancer	1.58e-06	4.23e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.56e-06	4.19e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TYMS—ovarian cancer	1.54e-06	4.11e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.5e-06	4.02e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.44e-06	3.84e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.31e-06	3.51e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—ovarian cancer	1.29e-06	3.46e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTEN—ovarian cancer	1.24e-06	3.32e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CAV1—ovarian cancer	1.24e-06	3.31e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.13e-06	3.03e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTEN—ovarian cancer	1.13e-06	3.03e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.13e-06	3.02e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.91e-07	2.65e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—ovarian cancer	9.25e-07	2.48e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CA—ovarian cancer	8.76e-07	2.34e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	8.64e-07	2.31e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CA—ovarian cancer	7.99e-07	2.14e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTEN—ovarian cancer	7.46e-07	2e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—ovarian cancer	7.15e-07	1.91e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—ovarian cancer	6.52e-07	1.75e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.27e-07	1.41e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—ovarian cancer	4.3e-07	1.15e-05	CbGpPWpGaD
